Dr. Rahmuddin khan, jamia hamdard, India
Dr. Rahmuddin is a skilled pharmaceutics researcher specializing in nano-based drug delivery systems for topical diseases, with a primary focus on psoriasis. Currently affiliated with the Nanomedicine Lab at Jamia Hamdard, New Delhi, he has a rich background in developing functional excipients and enhancing drug solubility through novel formulations. His academic path, from a Bachelor’s to a Ph.D. in Pharmaceutics at Jamia Hamdard, has cultivated his expertise across several scientific domains. Rahmuddin’s research includes hands-on experience with regulatory safety, non-clinical assessments, and industry-sponsored projects involving fulvic acid-based nanoformulations. Known for his analytical thinking, scientific writing, and mentorship, he has published extensively in reputable journals, showcasing advancements in nanoemulsion gels for conditions like psoriasis and tuberculosis. His collaborative work with New Zealand Fulvic Acid Limited and Reckitt Benckiser demonstrates his commitment to bridging industry with academic research for innovative therapeutic solutions.
Professional Profile:
Google Scholar
Suitability for the Best Researcher Award:
Dr. Rahmuddin is a highly deserving candidate for the Best Researcher Award due to his significant contributions to the field of pharmaceutics, particularly in the area of nano-based drug delivery systems for topical diseases such as psoriasis. His innovative research focuses on enhancing drug solubility and improving the effectiveness of topical treatments through novel formulations, including nanoemulsion gels. Dr. Rahmuddin’s academic background, culminating in his Ph.D. from Jamia Hamdard, showcases his deep understanding of pharmaceutics and his dedication to advancing drug delivery systems. His work with industry collaborators like New Zealand Fulvic Acid Limited and Reckitt Benckiser demonstrates his ability to bridge the gap between academia and industry, driving practical solutions for complex medical challenges.
🎓Education :
Rahmuddin completed his entire academic journey in Pharmaceutics at Jamia Hamdard, New Delhi, earning his Ph.D. in 2023. His doctoral thesis, titled “Novel Functional Excipient Appended System for Psoriasis,” explored advanced nano-based drug delivery systems, aimed at enhancing topical treatments. Prior to his Ph.D., he completed his M.Pharm in 2018, where he focused on “Exploration of Novel Peat-Sourced Fulvic Acid for Solubility Improvement of BCS Class II Drugs.” This research tackled the challenge of drug solubility by investigating natural compounds with pharmaceutical potential. He began his academic career with a B.Pharm in 2016 from the same institution, laying a solid foundation in pharmacy, pharmaceutics, and research methodologies. Throughout his academic journey, he developed strong technical expertise in drug formulation, excipient selection, and nano-delivery systems, equipping him with the necessary skills to innovate within the field of targeted drug delivery.
🏢Experience :
Rahmuddin’s professional experience spans academia, industry collaboration, and regulatory roles. His most recent role as a Consumer Safety Assistant at Reckitt Benckiser (May–Oct 2024) involved ensuring regulatory compliance and conducting non-clinical safety assessments. During his M.Pharm, he worked as a Research Associate on an industry-sponsored project with New Zealand Fulvic Acid Limited, focused on fulvic acid-based nanoformulations, an experience that honed his skills in drug delivery for pharmaceutical applications. His extensive research as a Ph.D. candidate at Jamia Hamdard (Dec 2018–Nov 2023) allowed him to specialize in topical drug delivery systems and provided opportunities to mentor M.Pharm and Ph.D. students. He has gained substantial laboratory experience, working with equipment like UV spectrophotometers, HPLC, tablet compression machines, and dissolution apparatuses, making him proficient in both theoretical knowledge and practical skills essential for pharmaceutical research.
🏅Awards and Honors :
Rahmuddin has received recognition for his work through various academic and industry-sponsored projects. Notably, his collaboration with New Zealand Fulvic Acid Limited on a project involving fulvic acid-based nanoformulations earned him significant acclaim, highlighting his contributions to innovative drug delivery research. His dedication to advancing drug solubility and effectiveness has been acknowledged within the academic community, where he has been a mentor and guide for students exploring solutions for complex diseases like psoriasis and tuberculosis. His publications in reputable journals, featuring targeted treatments and polysaccharide-based nano-drug delivery vehicles, showcase his commitment to expanding the applications of nano-based therapies. Through his professional experience and academic guidance, Rahmuddin continues to impact the field of pharmaceutics, bridging industry needs with academic insights to support advancements in the treatment of chronic diseases.
🔬Research Focus :
Rahmuddin’s research centers on the development of nano-based drug delivery systems for topical treatments, especially focusing on diseases like psoriasis. His work includes the creation of innovative excipients and nanoemulsion gels that improve drug solubility and targeted delivery, addressing issues faced with conventional formulations. In collaboration with New Zealand Fulvic Acid Limited, he has explored the pharmaceutical potential of fulvic acid for enhancing drug solubility, contributing to advancements in drug delivery systems. His technical skills encompass various analytical tools, including HPLC, UV spectrophotometry, and tablet compression machines, allowing him to design and assess complex formulations. Rahmuddin’s research portfolio spans a broad range of disease models beyond psoriasis, including acne and tuberculosis, exemplifying his commitment to leveraging nanotechnology for enhanced therapeutic outcomes. His contributions to scientific literature and mentorship to upcoming researchers further solidify his role as an innovative force in pharmaceutics.
Publication Top Notes:
-
“In vitro and in vivo investigation of a dual-targeted nanoemulsion gel for the amelioration of psoriasis”
-
“A pharmaco-technical investigation of thymoquinone and peat-sourced fulvic acid nanoemulgel: a combination therapy”
-
“Pharmacokinetic evaluation of fulvic acid-ketoconazole complexes: A validation and line extension study”
-
“Neuroprotective effects of trigonelline in kainic acid-induced epilepsy: Behavioral, biochemical, and functional insights”
-
“COVID-19 pandemic challenges and their management: A review of medicines, vaccines, patents and clinical trials with emphasis on psychological health issues”